Joseph E. Gilliam - Feb 8, 2024 Form 4 Insider Report for GLAUKOS Corp (GKOS)

Role
PRESIDENT & COO
Signature
Diana Scherer, Attorney-in-Fact
Stock symbol
GKOS
Transactions as of
Feb 8, 2024
Transactions value $
-$311,049
Form type
4
Date filed
2/12/2024, 06:41 PM
Previous filing
Jan 31, 2024
Next filing
Mar 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GKOS Common Stock Options Exercise $196K +5K +4.17% $39.10 125K Feb 8, 2024 Direct F1
transaction GKOS Common Stock Sale -$480K -5K -4.01% $96.07 120K Feb 8, 2024 Direct F1, F2, F3
transaction GKOS Common Stock Options Exercise $34.8K +631 +0.53% $55.18 120K Feb 9, 2024 Direct F1
transaction GKOS Common Stock Sale -$61K -631 -0.52% $96.70 120K Feb 9, 2024 Direct F1, F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GKOS Stock Option (Right to Buy) Options Exercise $0 -5K -16.41% $0.00 25.5K Feb 8, 2024 Common Stock 5K $39.10 Direct F5, F6
transaction GKOS Stock Option (Right to Buy) Options Exercise $0 -631 -1.5% $0.00 41.4K Feb 9, 2024 Common Stock 631 $55.18 Direct F5, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.
F3 This transaction was executed in multiple trades at prices ranging from $96.01 to $96.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $96.57 to $97.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.
F6 This option was granted on March 12, 2020 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date.
F7 Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.